Takumi Umemura, Hiromi Kakizaki, Yoshikazu Mutoh, Takahito Mizuno, Yuki Ito, Tatsuya Hioki, Hideo Kato, Mao Hagihara, Tetsuya Yamada, Yoshiaki Ikeda, et al. Effectiveness and safety of the simulation-based first-dose design of voriconazole. Journal of Infection and Chemotherapy. 2024
Hideo Kato, Mao Hagihara, Shun-Ichi Hiramatsu, Hiroyuki Suematsu, Naoya Nishiyama, Nobuhiro Asai, Hiroshige Mikamo, Kazuko Yamamoto, Takuya Iwamoto. Evaluating the antimicrobial efficacy of ceftriaxone regimens: 1 g twice daily versus 2 g once daily in a murine model of Streptococcus pneumoniae pneumonia. JAC-antimicrobial resistance. 2024. 6. 3. dlae092
Hideo Kato, Chihiro Shiraishi, Mao Hagihara, Hiroshige Mikamo, Takuya Iwamoto. Association between voriconazole-induced visual hallucination and dopamine in an analysis of the food and drug administration (FDA) adverse event reporting system database. Scientific reports. 2024. 14. 1. 12519-12519
Nobuhiro Asai, Yuichi Shibata, Atsuko Yamada, Wataru Ohashi, Mina Takayama, Yuzuka Kawamoto, Narimi Miyazaki, Daisuke Sakanashi, Tomoko Ohno, Akiko Nakamura, et al. Epidemiological study of respiratory syncytial virus infection in adults during the pandemic of COVID-19. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
Takumi Umemura, Hideo Kato, Nobuhiro Asai, Mao Hagihara, Jun Hirai, Yuka Yamagishi, Hiroshige Mikamo. Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci: a systematic review and meta-analysis. Heliyon. 2024. e29811-e29811